Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 272.50
Bid: 270.00
Ask: 275.00
Change: 30.00 (12.37%)
Spread: 5.00 (1.85%)
Open: 262.50
High: 272.50
Low: 255.00
Yest. Close: 242.50
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

24 May 18 16:10

Faron Says Traumakine Trial Did Not Produce Expected Results

LONDON (Alliance News) - Faron Pharmaceuticals Ltd said Friday that initial review of the Phase III trial for Traumakine drug used for the treatment of lung inflammation did not produce the seen a

11 May 18 08:45

WINNERS & LOSERS SUMMARY: Virgin Money Gains On CYBG Takeover Offer

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 4.1%. The Irish drugmaker said it has agreed

8 May 18 11:10

Faron Pharmaceuticals Shares Dive As Traumakine Fails In Latest Test

LONDON (Alliance News) - Shares in Finnish firm Faron Pharmaceuticals Oy plunged on Tuesday as the company reported "extremely disappointing" results from its flagship Traumakine shares

8 May 18 10:17

LONDON MARKET EARLY CALL: Stocks Called Lower As Iran Fears Boost Oil

LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday following Monday's UK bank holiday as Chinese exports recovered at a faster pace in April amid concerns the US

8 May 18 07:01

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 2 May Direct Line Insurance GroupQ1 ResultsConvaTec GroupQ1 GroupHalf

1 May 18 16:15

Tiziana Appoints Leopoldo Zambeletti As Non-Executive Director

LONDON (Alliance News) - Tiziana Life Sciences PLC, a biotechnology company developing drugs for cancer and autoimmune diseases, said Wednesday Leopoldo Zambeletti has joined

4 Apr 18 12:53

Faron Pharmaceuticals makes solid progress with drug programmes

(ShareCast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals updated the market on Thursday, ahead of its full year 2016 audited financial results which its board said will be announced on 29 March. The AIM-traded firm said for its Traumakine project, it expects to obtain the re

9 Feb 17 08:20

Faron Pharma granted protection for IFN-beta by Finnish patent office

(ShareCast News) - Faron Pharmaceuticals' patent application to protect the intravenous use of interferon-beta, a cytokine protein, in a novel formulation has been accepted by the Finnish patent office that enables the company to build a global proprietary position for its Traumakine drug. The claim

31 Oct 16 12:44

Faron Begins Recruitment For Japanese Phase 3 Traumakine Trial

24 Oct 16 08:33

Faron Pharma raises £8m to fund R&D

(ShareCast News) - AIM listed Faron Pharmaceuticals raised £8m through a share placing and subscription to fund safety trials, pre-clinical advances and various research and development operations in biopharmaceuticals. The Finland-based company raised £8m through a placing of about 2.86m shares and

21 Sep 16 15:13

Faron Pharmaceuticals Inks Licensing Deal For Traumakine In Korea

13 Jun 16 08:18

Faron Pharmaceuticals Expands Development Strategy For Clevegen

26 May 16 09:19

Faron Pharmaceuticals Appoints Medical Director Amid Expansion

3 May 16 08:24

Faron Pharmaceuticals Files Two Finnish Patents For Clevegen

19 Apr 16 08:03

Login to your account

Don't have an account? Click here to register.